ライフサイエンスコーパス: LFA

1 LFA based on-site rapid screening devices provide positi

2 LFA performance was consistent across different patient

3 LFA specificity could be increased by considering weak b

4 LFA-1 activity regulation was not affected.

5 LFA-1 cross-linking increased the presence of LAT-GRB2-S

6 LFA-1 inhibition blocked IFN-gamma secretion, splenocyte

7 LFA-1 is also needed to polarize the cytotoxic machinery

8 LFA-1 stimulation in PBMCs, CD4(+) T cells, or the T cel

9 LFA-1-activating antibodies and those inhibitory antibod

10 LFA-1-dependent endothelial surveillance by non-classica

11 LFA-1-FAK1 decreased T-cell-dendritic cell (DC) dwell ti

12 as it was 96.0% with P. aeruginosa The MCR-1 LFA and EDTA-CBDE methods are both accurate and user-fri

13 isolates were strongly positive by the MCR-1 LFA, with an additional 8 (3.4%) isolates yielding faint

14 ns lymphocyte function-associated antigen 1 (LFA-1) (alpha(L)beta(2)) and very late antigen 4 (VLA-4)

15 ns lymphocyte function-associated antigen 1 (LFA-1) (CD11a/CD18) and macrophage-1 antigen (CD11b/CD18

16 to lymphocyte function-associated antigen 1 (LFA-1) activation and leukocyte recruitment.

17 Lymphocyte function-associated antigen 1 (LFA-1) affinity and avidity changes have been assumed to

18 rmediates of leukocyte functional antigen 1 (LFA-1) form a concentric array at the immunological syna

19 ia lymphocyte function-associated antigen 1 (LFA-1) in the steady state.

20 Lymphocyte function-associated antigen 1 (LFA-1) mediated adhesion modulates TCR-pMHC tension by i

21 Lymphocyte functioning antigen 1 (LFA-1) on the surface of the target cell engaging with i

22 in lymphocyte-function-associated antigen 1 (LFA-1) signals.

23 Lymphocyte function-associated antigen 1 (LFA-1, CD11a/CD18, alphaLbeta2-integrin) and its ligands

24 in lymphocyte function-associated antigen 1 (LFA-1; CD11a/CD18) is a key T cell adhesion receptor tha

25 rin leukocyte function associated antigen-1 (LFA-1) is known to induce cross-talk to the alpha4beta1

26 of leukocyte function-associated antigen-1 (LFA-1) that was required for their survival within the g

27 he integrin lymphocyte functional antigen-1 (LFA-1) to migrate against the direction of shear flow on

28 in lymphocyte function-associated antigen-1 (LFA-1; CD11a/CD18) on white blood cells (WBCs) and causi

29 In 4 of 10 LFA-positive cases agreeing to LP, the cerebrospinal flu

30 ) and expressing adhesion molecules (VLA-4(+)LFA-1(+)) complementary to activated brain endothelium.

31 commended positivity threshold (GMI >= 0.5), LFA sensitivity and specificity were 96.9% (31/32) and 9

32 that with LFA-1 antibodies, we can activate LFA-1 and inhibit alpha4beta1, inhibit both LFA-1 and al

33 as IL-15, IL-12, or IL-18, does not activate LFA-1 but increases the responsiveness of the cells to s

34 nvestigate the signals necessary to activate LFA-1 in human NK cells.

35 ted with rapid colocalization of both active LFA-1 and DNAM-1 at the immune synapse.

36 oscillations such as low-frequency activity (LFA), high-frequency activity (HFA), or low-to-high cros

37 In addition, LFA-1 promoted expression of Bcl-6, a transcriptional re

38 though increased affinity mediates adhesion, LFA-1 cross-linking induced the association and activati

39 bit LFA-1 but not alpha4beta1, or not affect LFA-1 or alpha4beta1 These findings are important for th

40 regulating the accumulation of high-affinity LFA-1 in focal zones of adherent cells.

41 pendent readers had strong agreement for all LFA results (p < 0.0001).

42 yilin colocalized with integrin alphaLbeta2 (LFA-1) on T cells, and cross-linking layilin promoted th

43 -sensing constructs of integrin alphaLbeta2 (LFA-1) to visualize intramolecular tension during cell m

44 n is initiated by activation of alphaLbeta2 (LFA-1), which can be induced by rolling on E-selectin (s

45 on of JAM-A regulates leukocyte adhesion and LFA-1 binding.

46 ein expression, target cell conjugation, and LFA-1-, CD2-, and NKG2D-dependent activation of NK cells

47 (+) CD4 T cells and expression of CX3CL1 and LFA-3 in atherosclerotic plaque tissues from HIV-uninfec

48 LFA)-1 (alphaLbeta2) integrin expression and LFA-1-mediated T-lymphocyte functions.

49 phate-mediated intracellular Ca(2+) flux and LFA-1 activation that support chemokine-induced arrest i

50 cell receptors by enhancing calcium flux and LFA-1 integrin activation.

51 Vor homogenization, TruTip purification, and LFA amplification in a multisample, sputum-to-genotype s

52 ited to immune synapses along with talin and LFA-1, and loss of RIAM profoundly suppresses Ag-depende

53 ng chemomechanical crosstalk between TCR and LFA-1 receptor signaling.

54 le in the binding and trafficking of TCR and LFA-1 to the cell surface.

55 Although the T-cell receptor (TCR) and LFA-1 can generate intracellular signals, the immune cel

56 Anti-LFA-1 monoclonal antibody was used in a multiple minor a

57 .e. fibronectin, anti-CD3 antibody, and anti-LFA-1 antibody) were measured using impedance spectrosco

58 The anti-LFA-1 treatment led to fewer contacts between Tregs and

59 CD11c(+) cells, mice were treated with anti-LFA-1 Abs to reduce the number of CD11c(+) cells in this

60 pulse tolerance induction strategy with anti-LFA-1 rather than long-term treatment.

61 bited leukocyte function-associated antigen (LFA)-1 (alphaLbeta2) integrin expression and LFA-1-media

62 cking leukocyte function-associated antigen (LFA)-1 in organ transplant recipients prolongs allograft

63 that lymphocyte function-associated antigen (LFA-1) transferred onto LLV was able to trigger the clus

64 useful first step in the development of any LFA format.

65 and identified the cell surface receptor as LFA-1 (CD11a/CD18; alphaLbeta2 integrin).

66 eded for the activation of integrins such as LFA-1 is poorly understood.

67 the recently released IMMY sona Aspergillus LFA when testing serum samples.

68 The IMMY sona Aspergillus LFA, when used with a cube reader, provides a rapid alte

69 ococcal antigen (CrAgSQ) lateral flow assay (LFA) against the current gold standard CrAg tests.

70 A lateral flow assay (LFA) can provide a rapid and cost-effective means to det

71 with development of the lateral flow assay (LFA) having reported increased sensitivity and specifici

72 acid hybridization-based lateral flow assay (LFA) holds great potential to address these limitations

73 spergillus Galactomannan Lateral Flow Assay (LFA) is a rapid test for the diagnosis of invasive asper

74 rapid, semi-quantitative lateral flow assay (LFA) was developed to screen the oxytetracycline (OTC) a

75 a novel semiquantitative lateral flow assay (LFA), CryptoPS, that may be able to identify individuals

76 e available, including a lateral flow assay (LFA).

77 ic of the antibody-based lateral flow assay (LFA).

78 proof of concept for the lateral flow assay (LFA).

79 A new lateral flow assay (LFA, Sona, IMMY, Norman OK) improves time-to-result to o

80 Here we present a novel liposome flux assay (LFA) that is applicable to most K(+) channels.

81 CrAg was measured using lateral flow assays (LFA) and latex agglutination (LA) tests in 645 HIV-posit

82 Lateral flow assays (LFA) are a simple method for use outside specialist cent

83 we evaluated two rapid lateral flow assays (LFA) for detection of Mycobacterium leprae-specific anti

84 and quick operation of lateral flow assays (LFA) have made them some of the most common point of car

85 This Lab-on-a-Film assembly (LFA) serves as a platform for amplification, hybridizati

86 dingly, LAYN deletion resulted in attenuated LFA-1-dependent cellular adhesion.

87 over the currently available antibody-based LFA systems for influenza viruses, which offer discrimin

88 Qualitative agreement between LFA and GM-EIA was 89.0%, generating a Kappa statistic o

89 ntation rely on a bistable mechanism between LFA-1-mediated upstream and VLA-4-mediated downstream ph

90 there exists a molecular cross-talk between LFA-1 and Notch1 through the Akt/ERK-GSK3beta signaling

91 Blocking LFA-1 by a neutralizing Ab or specific inhibition of Not

92 Furthermore, blocking LFA-1-induced MTOC polarization through ZAP70 inhibition

93 However, both LFA and LA appear to be less sensitive in HIV-negative p

94 LFA-1 and inhibit alpha4beta1, inhibit both LFA-1 and alpha4beta1, inhibit LFA-1 but not alpha4beta1

95 In sum, both LFA-1 and Mac-1 binding ICAM-1 play a critical role in d

96 egative GM-EIA samples that were positive by LFA.

97 erse range of downstream signaling cascades, LFA-1 stimulation in T lymphocytes modulates gene-transc

98 They also expressed CXCR3/CCR5/LFA-1 trafficking/tissue-resident phenotypes and consist

99 osis via CX3CR1-mediated trafficking and CD2/LFA-3-mediated costimulation.

100 the costimulatory receptor CD2 and that CD2/LFA-3 costimulation results in a more robust and polyfun

101 on of the structurally related protein CD58 (LFA-3) is associated with disease remission in MS.

102 nal enhancement compared to the conventional LFA for Human IgG (H-IgG) detection.

103 ent in detection limit over the conventional LFA when detecting Escherichia coli, all while maintaini

104 CrAg LFA and LA titers were correlated but were not directly

105 ing guidelines (CD4 < 200 cells/mm(3)), CrAg LFA testing of venous whole blood, fingerprick capillary

106 infection for 20 patients (52.6%), and CrAg LFA titers in serum and CSF samples ranged from 1:5 to >

107 nce was measured using the FDA-approved CrAg LFA (IMMY) as a reference standard via McNemar's test.

108 ryptococcal antigen lateral flow assay (CrAg LFA) was evaluated for the diagnosis of cryptococcosis i

109 yptococcal antigen lateral flow assays (CrAg LFA) may expedite treatment of HIV-associated cryptococc

110 ons, we sought to validate clinic-based CrAg LFA testing.

111 All venous and fingerprick whole blood CrAg LFA tests were positive among 30 hospitalized adults wit

112 ng to LP, the cerebrospinal fluid (CSF) CrAg LFA was positive.

113 nt with targeted therapy and decreasing CrAg LFA titers.

114 The remaining 13 patients had CrAg LFA titers of 1:2 (n = 11) or 1:5 (n = 2) and were ultim

115 ty compared to the results for the IMMY CrAg LFA and provided CrAg scores that were associated with b

116 Using the IMMY CrAg LFA as a reference standard, CrAgSQ was 93.0% sensitive

117 he CrAgSQ LFA and the conventional IMMY CrAg LFA, of which 692 were sequential samples from HIV-posit

118 at the point-of-care by trained nurses, CrAg LFA testing was feasible, had the highest accuracy on se

119 rovement (n = 2), leading to an overall CrAg LFA false-positive rate of 34%.

120 between whole blood, serum, and plasma CRAG LFA results demonstrates that fingerstick CRAG is a reli

121 reviews for all patients with positive CrAg LFA results between June 2014 and December 2016.

122 le cases of low-titer (</=1:5) positive CrAg LFA results in patients for whom cryptococcosis was ulti

123 gate the accuracy of low-titer positive CrAg LFA results, we performed chart reviews for all patients

124 n for patients with first-time positive CrAg LFA titers of 1:2.

125 llary and venous whole blood with rapid CrAg LFA (Immy Diagnostics, Norman, USA).

126 When tested on serum samples, CrAg LFA had sensitivity of 93% (95% CI 66-100%) and specific

127 57 were CrAg positive (CrAg(+)) by the CrAg LFA reference standard.

128 or histopathological confirmation, the CrAg LFA results were considered true-positive results for 5

129 We evaluated the accuracy of the CRAG LFA using fingerstick whole blood compared with serum/pl

130 rom 3,969 patients were tested with the CrAg LFA, and 55 patients (1.5%) tested positive.

131 Despite excellent performance of the CrAg LFA, we have observed multiple cases of low-titer (</=1:

132 assay missed 35% (7/20) of samples with CrAg LFA titers of <=1:20.

133 ma samples were tested using both the CrAgSQ LFA and the conventional IMMY CrAg LFA, of which 692 wer

134 in inhibition of Rap1 activity and decreased LFA-1-mediated adhesion.

135 When CM is a possible diagnosis, LFA identified nearly a third of EIA+ infections.

136 Using different LFA-1 monoclonal antibodies, we have been able to study

137 The daughter CD8(+) T cells with disparate LFA-1 expression showed different patterns of migration

138 Compared to standard EIA, LFA demonstrates 31% sensitivity (95% CI of 20%-44%) and

139 to detect targets in situ; however, existing LFA formats (predominantly sandwich assays) are not suit

140 em and progenitor cells, neutrophils express LFA-1, but they also express macrophage-1 antigen (Mac-1

141 the specificity of LtxA for cells expressing LFA-1.

142 tivity for LA was 94.7% compared to 100% for LFA in patients with disseminated disease.

143 tivity by LA was 78.1% compared to 82.6% for LFA.

144 sensitivity was 23.5% compared to 90.9% for LFA.

145 ely, our results define unique functions for LFA-1 in the Tfh cell effector program and suggest that

146 verall, our findings outline a new model for LFA-1 in which the integrin can mediate both adhesion an

147 first time membrane components required for LFA in milk system was optimized.

148 all expressed GNB isoforms are required for LFA-1 activation.

149 4%(n = 15) were detected by UCP-LFA and Gold-LFA, respectively.

150 entified by UCP-LFA and 78%(n = 133) by Gold-LFA.

151 mmunogold OnSite Leprosy Ab Rapid test [Gold-LFA] and the quantitative, luminescent up-converting pho

152 th HIV (PLWH), 76 had LA testing, and 10 had LFA testing.

153 tive patients, 107 had LA testing and 34 had LFA testing.

154 The lateral flow immunoassay (LFA) is one of the most widely used point-of-care diagno

155 tests, such as the lateral-flow immunoassay (LFA), provide a promising alternative to the traditional

156 the NG-Test MCR-1 lateral flow immunoassay (LFA; NG Biotech, Guipry, France) and (ii) the EDTA-colis

157 ) of CryptoPS were assessed against the IMMY LFA as a reference.

158 ositive by CryptoPS but negative by the IMMY LFA, none developed cryptococcal meningitis over 3 month

159 was tested for CrAg by CryptoPS and the IMMY LFA; the two assays were conducted by two different oper

160 er (T2 band) results were compared with IMMY LFA titers obtained through serial dilution.

161 pression of SOS1, ARHGEF1, and DOCK2 impairs LFA-1-mediated rapid T lymphocyte adhesion as well as un

162 The improved LFA holds great potential for diseases diagnostics, food

163 edge, most likely resulting from a defect in LFA-1 release required for forward movement.

164 vity is reduced, resulting in an increase in LFA-1 adhesion compared to that for syngeneically activa

165 e prepared and used as labelling material in LFA.

166 o-related gene) channel, which, when used in LFA, provides a highly sensitive (zero false negatives o

167 particles provide an opportunity to increase LFA sensitivity and impart novel capabilities.

168 cell subsets vary in their ability to induce LFA-1 binding activity after activating receptor stimula

169 okinesis (DOCK)2 GEFs mediate CXCL12-induced LFA-1 activation in human primary T lymphocytes.

170 inhibit both LFA-1 and alpha4beta1, inhibit LFA-1 but not alpha4beta1, or not affect LFA-1 or alpha4

171 a-secretase inhibitor substantially inhibits LFA-1/ICAM-1-mediated activation of Notch signaling.

172 rentially binds the alpha(L)beta(2) integrin LFA-1 (CD11a/CD18) of leukocytes and can promiscuously b

173 The alphaLbeta2 integrin LFA-1 is known to play a key role in T lymphocyte migrat

174 icular, redistribution of the beta2 integrin LFA-1 to the immunological synapse is compromised in Cav

175 eficient NK cells were dependent on integrin LFA-1 but not on DNAM-1 or NKG2D.

176 VS and show that cross-linking the integrin LFA-1 alone is sufficient to induce active T cell polari

177 In this study, we report that the integrin LFA-1 cross-linking with its ligand ICAM-1 in human PBMC

178 The integrin LFA-1 is essential for efficient activation and for cyto

179 Here, we show that the integrin LFA-1 triggers organelle polarization and viral protein

180 sence of additional ligands for the integrin LFA-1, this biphasic response is abrogated and the cell

181 ccurs through interactions with the integrin LFA-1.

182 by Treg cells was due, in part, to integrin LFA-1-mediated interactions between Treg cells and dendr

183 Notably, CsA inhibited integrin-LFA-1-dependent and NFAT-independent adhesion of T cells

184 The analysis of beta2 integrins LFA-1 and macrophage-1 Ag (Mac-1) showed that in CD45E61

185 , which in turn activate multiple integrins (LFA-1, VLA-4), adhesion molecules (ICAM-1, MadCAM-1) and

186 sensitivity by integrating sponge shunt into LFA to decrease the fluid flow rate.

187 Intracellular LFA-1 quickly translocated to the cell surface with anti

188 rtantly, the redistribution of intracellular LFA-1 at the contact with APC was maintained during cell

189 an important regulator of the intracellular LFA-1 translocation.

190 LAM LFA had a sensitivity of 75% for definite histopathologi

191 LAM LFA in CSF is a useful additional diagnostic tool.

192 We performed LAM LFA (on unprepared and supernatant CSF after heating and

193 r biomarker, using its physiological ligand, LFA-1.

194 e immune cell adaptor protein SKAP1 mediates LFA-1 activation induced by antigen-receptor (TCR/CD3) l

195 Combined with PCT &0.25 ng/ml, LFA could reduce unnecessary antibacterial use by 77%.

196 kine receptor (CXCR3) and adhesion molecule (LFA-1) expression by T cells, and downregulation of cyto

197 Moreover, LFA-1 affinity triggering by CXCL12 is impaired by SOS1,

198 bition of Pyk2 caused cells to form multiple LFA-1-rich tails at the trailing edge, most likely resul

199 hosphatase SHP-1 in the regulation of murine LFA-1-mediated adhesion in an allograft setting.

200 showed that in CD45E613R mutant neutrophils LFA-1 adhesiveness was impaired, and avidity was enhance

201 We present a new LFA design that probes the dissociation of aptamers from

202 ce resonance energy transfer (FRET) with new LFA-1-specific fluorescent probes showed that triggering

203 hGAP15 specifically regulates Mac-1, but not LFA-1, and affects leukocyte recruitment by controlling

204 drugs restricts the quantitation ability of LFA strips.

205 Cav1-knockout T cells, as is the ability of LFA-1 to form high-avidity interactions with ICAM-1.

206 otential also show the highest activation of LFA-1, which correlated with the expression of the small

207 M-1-mediated proliferation and activation of LFA-1-expressing ILC2s.

208 the T cell receptor for agonist pMHC and of LFA-1 (lymphocyte function-associated antigen 1) for ICA

209 aintaining the high affinity conformation of LFA-1, for increasing valency by recruiting LFA-1 to the

210 icient mice and involves the contribution of LFA-1 (lymphocyte-associated antigen 1) and alpha4 integ

211 A common criticism of LFA tests is that they have poor detection limits compar

212 ISG15 engagement of LFA-1 led to the activation of SRC family kinases (SFKs)

213 evented the generation of activated forms of LFA-1.

214 egulation led to a significant impairment of LFA-1 activation, which was demonstrated in vitro and in

215 ivision and led to an unequal inheritance of LFA-1 in divided T cells.

216 Tfh cell differentiation, and inhibition of LFA-1 abolished Tfh cell generation and prevented protec

217 The low detection limit of LFA and associated long equilibration times are due to k

218 ITP improves the LoD of LFA to the level of some lab-based immunoassays, such as

219 e to improve the limit of detection (LoD) of LFA by 400-fold for 90 s assay time and by 160-fold for

220 ta demonstrate that an intracellular pool of LFA-1 in naive CD8(+) T cells plays a key role in T cell

221 reserve a significant intracellular pool of LFA-1 in the uropod during migration.

222 isms underlying the therapeutic potential of LFA-1 blockade in preventing chronic rejection are not f

223 Our data suggest that regulation of LFA-1 is one reason for the different activity of NK cel

224 novel key role of SHP-1 in the regulation of LFA-1-mediated adhesion may provide a new insight into T

225 ures, but the poor analytical sensitivity of LFA restricts its application.

226 d an accumulation of surface Env at sites of LFA-1 engagement, with intracellular Env localized to a

227 ell recognition, the conformational state of LFA-1 changed in educated NK cells, associated with rapi

228 ced by cytokines and leads to suppression of LFA-1 activity.

229 s, combined with an inhibiting cross talk of LFA-1 toward VLA-4.

230 Although clinical use of LFA-1 antagonists is limited by toxicity related to immu

231 nd in contrast to Th1 cells, Tregs depend on LFA-1 for their entry into the CNS in the absence of Itg

232 the Notch pathway activation is dependent on LFA-1/ICAM-1-induced inactivation of glycogen synthase k

233 ies levels to SACOL0688 in SF using ELISA or LFA provides a tool for the sensitive and specific diagn

234 , L-selectin and Mac-1 but not P-selectin or LFA-1.

235 link between actin and the receptors (TCR or LFA-1), rather than the ligand/receptor linkage, is the

236 Additionally, we show that our LFA design is not confined to the specific proteins used

237 exclusively until April 2016, at which point LFA was used exclusively.

238 ne signaling with timing coherent with rapid LFA-1 affinity activation.

239 acts as a ligand for the leukocyte receptor LFA-1.

240 LFA-1, for increasing valency by recruiting LFA-1 to the immunological synapse, and ultimately for p

241 rk generates mechanical forces that regulate LFA-1 activity at the immunological synapse.

242 f Talin-1, an adaptor protein that regulates LFA-1 affinity, dictated Tfh versus Th2 effector cell di

243 termination and reader training for reliable LFA deployment.

244 flow from surrounding regions' HFA to SOZ's LFA or increased information flow from SOZ's LFA to surr

245 LFA or increased information flow from SOZ's LFA to surrounding regions' HFA.

246 The SACOL0688 LFA demonstrated 100% specificity and 100% sensitivity.

247 ssociated with higher screening plasma/serum LFA titers.Among the 28 CrAg-positive patients, mortalit

248 Development of a half-strip LFA is a useful first step in the development of any LFA

249 oint of care setting, though this half-strip LFA may serve as a useful starting point for others deve

250 In this work, we present a half-strip LFA using commercially available antibodies for the dete

251 Finally, short-term LFA-1 blockade promoted long-term donor-specific regulat

252 We argue that LFA-1 contact with a cognate ligand, such as ICAM-1, ind

253 es coupled with inhibitors demonstrated that LFA-1-induced polarization was dependent on the T cell k

254 Taken together, these data reveal that LFA-1 is a key determinant in inducing dynamic T cell re

255 We show that LFA-1 and Fas are early events in the LtxA-mediated cell

256 Here, we show that LFA-1 can mediate both adhesion and de-adhesion, depende

257 Our data show that LFA-1 has a low ligand-binding activity in resting human

258 The LFA may serve a role as a rapid test that may replace co

259 The LFA showed an area under the curve (AUC) of 0.865 (95% C

260 The LFA was performed following the manufacturer's instructi

261 The LFA-1 blockade prevented acute rejection and preserved p

262 The LFA-1 blockade profoundly attenuated neointimal hyperpla

263 The LFA-1 blockade significantly suppressed the clonal expan

264 CyaA(1-710)/HlyA(411-1024) chimera bound the LFA-1 receptor and effectively delivered AC into Jurkat

265 The median GMI generated by the LFA was significantly greater than that generated by the

266 lled 392 suspected CM patients, compared the LFA to standard EIA and included procalcitonin evaluatio

267 ccompanied by weaker information flow in the LFA from the surrounding regions to SOZ.

268 ment, demonstrates that perturbations in the LFA-1-C3-axis contribute to primary immunodeficiency, an

269 Development of the LFA diagnostic modality is a desirable, cost-effective o

270 lassification, diagnostic performance of the LFA was highly similar to GM testing (AUC 0.892 versus 0

271 ation and nanozyme signal enhancement on the LFA, resulting in a 30-fold improvement in detection lim

272 entration and detection of biomarkers on the LFA.

273 In this multicenter study the LFA assay from BALF demonstrated good diagnostic perform

274 s into a thin band and transport them to the LFA capture line, resulting in a dramatic increase in th

275 However, interaction with the LFA-1 receptor strongly enhanced the specific capacity o

276 The limit of detection of this LFA was 0.13 ng/mL IgE, approximately 100 times lower th

277 We have tested this LFA in buffer and measured an LOD of 0.65 ng/mL (95% CI

278 ntly implicated in binding of human ISG15 to LFA-1 in vitro were required for its adjuvant effect in

279 mprovement in sensitivity from LA testing to LFA testing, predominantly in those with localized pulmo

280 Taken together, LFA-1 blockade inhibits initial endogenous alloreactive

281 pposed by immobilized ICAM-1, which triggers LFA-1 activation through a combination of induced fit an

282 = 161) of MB patients were identified by UCP-LFA and 78%(n = 133) by Gold-LFA.

283 n = 14) and 44%(n = 15) were detected by UCP-LFA and Gold-LFA, respectively.

284 up-converting phosphor anti-PGL-I test [UCP-LFA].

285 rly higher sensitivity obtained with the UCP-LFA assay.

286 Therefore, the UCP-LFA platform, which allows multiplexing with differentia

287 t can be interpreted as a previously unknown LFA-1 conformation.

288 as compared to 10(4) copies/ml in unmodified LFA.

289 testing of HBV as compared to the unmodified LFA.

290 otes the conjugate formation by upregulating LFA expression on NK cells and by inducing ICAM-1 expres

291 These included 16 also positive by urine LFA (2.5% of total screened) and 7 by serum LA (1.1% of

292 Using LFA, we performed small molecule screens on three differ

293 ls enables neutrophils to adhere firmly, via LFA-1-mediated binding to ICAM-1 constitutively expresse

294 rection of fluid flow on ICAM-1 surfaces via LFA-1 if Mac-1 is blocked; otherwise, they migrate downs

295 and discusses molecular mechanisms by which LFA-1 signaling influence T lymphocyte differentiation i

296 eling to the VS and suggest a model in which LFA-1 engagement triggers active polarization of the MTO

297 d segment and/or the RTX domain of HlyA with LFA-1 promoted a productive membrane interaction of the

298 concentrations (25 nm), the interaction with LFA-1 was not required for CyaA(1-710)/HlyA(411-1024) bi

299 were CrAg positive in serum and plasma with LFA.

300 The results show that with LFA-1 antibodies, we can activate LFA-1 and inhibit alph